Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-06T09:44:31.370Z Has data issue: false hasContentIssue false
  • English
  • Français

A Clinical Trial of Stemetil (Prochlorperazine)

Published online by Cambridge University Press:  08 February 2018

Hugo B. Milne  and
Fritz Berliner
Hugo B. Milne
Affiliation:
Pastures Hospital, Mickleover, Derby
Fritz Berliner
Affiliation:
Pastures Hospital, Mickleover, Derby
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Phenothiazine derivatives have been widely employed in the management of schizophrenia over the past few years. Possibly the most commonly used has been chlorpromazine under its trade name “Largactil”.

Type
Original Articles
Information
Journal of Mental Science , Volume 104 , Issue 436 , July 1958 , pp. 873 - 879
Copyright
Copyright © Royal College of Psychiatrists, 1958 

References

1. Baker, A. A., and Thorpe, J. G., “Deteriorated Psychotic Patients—their Treatment and its Assessment”, J. Ment. Sci., 1956, 102, 780–789.CrossRefGoogle Scholar
2. Broussolle, P., and Dubor, P., “Preliminary Appraisal of the Clinical Effects of a New Neuroleptic”, Congr. Alién, Neurol., Bordeaux, 1956.Google Scholar
3. Ducrot, R., and Koetschet, P., “Anti-emetic Properties of a New Phenothiazine Derivative 3-Chloro-10-(3-N-methyl-piperazinylpropyl)-phenothiazine (6140 R.P.)”, Int. Physiol. Congr., Brussels, 1956.Google Scholar
4. Smithy, G., and Homburger, F., “Prochlorperazine for the Treatment of Nausea and Vomiting in Patients with Advanced Cancer and other Chronic Diseases”, New Eng. J. Med., 1957, 256, 27.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.